Overexpression of TPX2 predicts poor clinical outcome and is associated with immune infiltration in hepatic cell cancer

Targeting protein for Xenopus kinesin-like protein 2 (TPX2) has been identified as an oncogene in multiple cancers. However, the associations among TPX2 expression, prognosis, and tumor immunity in hepatic cell cancer (HCC) have not been explored. We analyzed TPX2 expression by multiple gene express...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Hongjun, Liu, Jian, Feng, Jia, Zhang, Qing, Bian, Tingting, Li, Xiaoli, Sun, Hui, Zhang, Jianguo, Liu, Yifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717782/
https://www.ncbi.nlm.nih.gov/pubmed/33285774
http://dx.doi.org/10.1097/MD.0000000000023554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717782/
https://www.ncbi.nlm.nih.gov/pubmed/33285774
http://dx.doi.org/10.1097/MD.0000000000023554

Ejemplares similares